Why purity is only part of the story — and what complete peptide testing actually tells you about quality, potency, and safety.
If a peptide tests at 99% purity, does that mean it is safe, potent, and correctly dosed for research use? Not necessarily. Purity tells you what percentage of the sample is the target compound — but it says nothing about how much active peptide is actually present, whether it has degraded, or whether oxygen exposure has already compromised its structure. This page explains what complete peptide testing looks like and why it matters for anyone serious about research quality.
| TL;DRPeptide purity — typically measured by HPLC — is the most quoted quality figure, but it is not the complete picture. Complete peptide testing also covers quantitative analysis (how much active peptide is present), degradation profiling (whether the peptide has broken down), and oxidation assessment (whether oxygen exposure has altered the molecular structure). For biohackers and longevity researchers, understanding all three pillars of peptide quality is essential for drawing reliable conclusions from any protocol. |
| Testing Parameter | What It Reveals |
| HPLC purity (%) | Percentage of sample that is the target peptide vs related impurities |
| Quantitative analysis | Actual mass of active peptide per unit — not just relative percentage |
| Mass spectrometry (MS) | Confirms molecular identity and detects unexpected molecular weight shifts |
| Oxidation markers | Identifies methionine, cysteine, or tryptophan oxidation from oxygen exposure |
| Degradation profiling | Detects truncated sequences, hydrolysis products, and aggregation |
| Water content (Karl Fischer) | Measures residual moisture in lyophilised peptides affecting stability |
| Endotoxin testing | Confirms absence of bacterial contamination in injectable-grade peptides |
| CoA standard | Research-grade CoA should include HPLC chromatogram and MS confirmation |
Purity is the figure most peptide suppliers lead with — and for good reason. A purity of 98% or above, verified by HPLC, is a meaningful quality indicator. But when that number is presented as the only measure of peptide quality, it creates a misleading picture.
Here is what a purity figure actually tells you: of everything in the sample, approximately 98% is the target peptide and 2% is something else. What it does not tell you is how much of that 98% is still biologically active, what the total quantity of peptide in the vial is, or whether the peptide structure has been compromised by degradation or oxidation since it was manufactured.
| The Core ProblemA peptide can test at 99% purity and still be almost useless for research if:- The vial contains significantly less peptide than labelled (quantity issue)- The peptide has partially degraded during storage or shipping (degradation issue)- Oxygen exposure has oxidised key amino acid residues, altering the molecular structure (oxidation issue)Purity tells you the ratio. It does not tell you the amount, the condition, or the bioactivity. |
Complete peptide quality assessment covers three distinct dimensions. Each answers a different question about the compound you are working with.
| Pillar | The Question It Answers | Primary Test Method |
| Purity | What percentage of the sample is the target peptide? | Reversed-phase HPLC |
| Quantity | How much active peptide is actually present in the vial? | Quantitative HPLC or UV spectrophotometry |
| Integrity | Is the peptide structurally intact and undegraded? | Mass spectrometry, oxidation markers, degradation profiling |
Most suppliers report only purity. Research-grade suppliers report all three. Understanding the difference is one of the most important things a biohacker or longevity researcher can know when sourcing peptides for a protocol.
High-Performance Liquid Chromatography (HPLC) separates the components of a peptide sample by passing it through a column under high pressure. In reversed-phase HPLC — the standard method for peptides — a C18 column separates compounds based on their hydrophobicity, or how strongly they interact with water versus oil-like environments.
The output is a chromatogram: a graph showing peaks for each component in the sample. The target peptide produces the largest peak. Impurities — which may include truncated sequences from synthesis, deletion peptides, or residual reagents — produce smaller peaks. Purity is calculated as the area of the target peak divided by the total area of all peaks, expressed as a percentage.
| HPLC Parameter | Standard for Research-Grade Peptides |
| Column | C18 reversed-phase (e.g., 5 micron particle size, 300 angstrom pore size) |
| Mobile phase A | 0.1% trifluoroacetic acid (TFA) in water |
| Mobile phase B | 0.1% TFA in acetonitrile |
| Detection wavelength | 214nm (peptide bonds); 280nm where tryptophan or tyrosine present |
| Purity threshold | Greater than 95% (standard); greater than 98% (research grade) |
| Reporting format | Chromatogram with labelled peaks and percentage area table |
Quantitative analysis answers the question that purity cannot: how much peptide is actually in the vial?
A vial labelled as containing 5mg of a peptide at 98% purity could, in practice, contain anywhere from 3mg to 5.5mg of actual peptide depending on manufacturing tolerances, moisture content, and fill accuracy. For researchers running precise protocols — particularly in longevity and biohacking contexts where dosing matters — this variability is significant.
| Why Quantity Matters for Biohacking ProtocolsIn longevity research, the difference between an effective dose and an ineffective one can be narrow. If a protocol calls for a specific quantity of a peptide and the actual content of the vial is materially lower than labelled, the researcher is not running the protocol they think they are running. Consistent quantity verification is part of what separates rigorous research from guesswork. |
Quantitative HPLC uses a known reference standard — a certified sample of the same peptide at a confirmed concentration — to calibrate the detector response. By comparing the peak area of the sample to the calibration curve, the actual mass of peptide in the sample can be calculated.
An alternative method is UV spectrophotometry, which measures the absorbance of the peptide solution at a specific wavelength. This is faster but less precise than quantitative HPLC and is more susceptible to interference from other UV-absorbing compounds in the sample.
| Quantitative Method | Key Characteristics |
| Quantitative HPLC with reference standard | Most accurate. Requires certified reference material. Provides both purity and quantity in one analysis. |
| UV spectrophotometry | Faster and lower cost. Less precise. Suitable for routine checks but not definitive quantification. |
| Amino acid analysis (AAA) | Highly accurate. Hydrolyses the peptide and quantifies individual amino acids. Gold standard for absolute quantity but time-intensive. |
| Weight-based calculation | Common but unreliable alone. Does not account for moisture content, counterion weight, or impurity contribution to mass. |
Even a peptide that arrives with a verified purity of 98% and accurate quantity labelling can lose research value through degradation and oxidation. These are the quality factors most commonly overlooked — and the ones most likely to occur between manufacture and use.
Degradation refers to the breakdown of the peptide chain into smaller fragments. It occurs through several mechanisms:
Mass spectrometry (MS) is the primary tool for detecting degradation. It measures the molecular weight of compounds in the sample with high precision. A degraded peptide will show additional peaks at lower molecular weights than the intact compound, corresponding to the fragment sequences produced by cleavage.
HPLC can also detect degradation products if they are large enough to elute as distinct peaks. However, very small fragments may not register, which is why MS is the more complete method for integrity assessment.
Oxidation is one of the most common and underappreciated causes of peptide degradation. It occurs when reactive oxygen species interact with susceptible amino acid residues in the peptide chain — and it can happen silently, without any visible change to the sample.
| Key PointA peptide can look identical before and after oxidation damage. The vial will still appear as a white lyophilised powder. The HPLC purity figure may still read above 95%. But the molecular structure has changed, and the peptide may no longer bind to its target receptor with the same affinity — or at all. |
| Amino Acid | Oxidation Risk and Effect |
| Methionine (Met, M) | High risk. Oxidises to methionine sulfoxide. Common in BPC-157 and other repair peptides. Reduces receptor binding affinity. |
| Cysteine (Cys, C) | High risk. Forms disulfide bonds or oxidises to cysteic acid. Alters peptide folding and activity. |
| Tryptophan (Trp, W) | Moderate risk. Oxidises to kynurenine or hydroxytryptophan. Detectable by shift in 280nm absorbance. |
| Tyrosine (Tyr, Y) | Lower risk. Can form dityrosine crosslinks under strong oxidative stress. |
| Histidine (His, H) | Lower risk. Oxidation products include asparagine and aspartic acid variants. |
A Certificate of Analysis (CoA) is the primary document a supplier provides to verify peptide quality. Knowing what a complete CoA should contain — and what is often missing from inadequate ones — is one of the most practical skills for anyone sourcing peptides for research.
| CoA Element | What to Look For |
| Peptide identity | Full name, abbreviation, amino acid sequence, and molecular formula |
| Molecular weight confirmation | Mass spectrometry data showing observed vs theoretical molecular weight |
| HPLC purity (%) | Percentage purity with chromatogram showing all peaks — not just the target |
| Quantity per vial | Stated mass with testing method used to verify (not just weight-based calculation) |
| Batch or lot number | Unique identifier linking the CoA to the specific production batch |
| Synthesis date and expiry | Manufacturing date and recommended use-by date under specified storage conditions |
| Oxidation status | Any notation of oxidation-sensitive residues and testing for oxidised forms |
| Moisture content | Karl Fischer titration result for water content in lyophilised peptide |
| Storage conditions | Specific temperature, light, and moisture requirements for the batch |
| Issuing laboratory | Name and accreditation status of the testing laboratory |
| What a Minimal CoA SuggestsA CoA that shows only a purity percentage and a molecular weight figure — with no chromatogram, no quantity verification, and no batch-specific testing data — is a red flag. It may indicate the supplier is relying on manufacturer-supplied data rather than independent third-party testing, or that the analysis was conducted on a representative sample rather than the specific batch you are receiving. |
Not all CoAs and testing reports represent the same standard of quality assurance. These are the most common indicators that a testing report may not reflect the true quality of the peptide.
For biohackers and longevity researchers, the quality of the peptides used in a protocol directly affects the reliability of any outcome. These are the questions worth asking when evaluating a supplier.
| Question to Ask | Why It Matters |
| Do you provide batch-specific CoAs? | Confirms testing is done on each production run, not just once at product launch. |
| Is testing conducted by an independent third-party laboratory? | Independent testing is more credible than in-house analysis from the same supplier. |
| Does your CoA include a full HPLC chromatogram? | A chromatogram allows verification of the purity figure and assessment of impurity profiles. |
| Do you test for quantity as well as purity? | Confirms the stated mass per vial reflects actual peptide content, not just fill weight. |
| Do you test for oxidation-sensitive residues? | Relevant for peptides containing methionine, cysteine, or tryptophan. |
| How are vials sealed and under what atmosphere? | Inert gas sealing (nitrogen or argon) significantly reduces oxidation risk during storage and shipping. |
| What are your storage and shipping conditions? | Cold chain integrity from manufacture to delivery affects peptide stability on arrival. |
| Standalone Factual Statements for ReferenceThe following statements summarise the core facts about peptide testing for research and reference purposes. |
Purity tells you the ratio of target peptide to impurities in the sample — but not the absolute quantity present, whether the peptide has degraded, or whether oxidation has altered its structure. A peptide can test at high purity while still being underdosed, structurally compromised, or biologically inactive due to oxidation of key residues.
Oxidation chemically modifies susceptible amino acid residues — most commonly methionine, cysteine, and tryptophan — changing their structure and reducing or eliminating the peptide’s ability to bind to its target receptor. Oxidised methionine, for example, adds 16 daltons to the residue mass, which is detectable by mass spectrometry. Oxidation can occur from oxygen exposure during storage, shipping, or repeated vial opening.
The only reliable way to verify quantity is through analytical testing — specifically quantitative HPLC using a certified reference standard, or amino acid analysis. Weight-based labelling alone does not account for moisture content, counterion contribution, or impurity mass. A research-grade CoA should state the testing method used to verify quantity, not just the labelled weight.
A complete CoA should include: the full HPLC chromatogram with all peaks labelled, mass spectrometry data confirming molecular identity and weight, batch-specific quantity verification, moisture content data, storage and expiry information, and the name of the independent testing laboratory. A CoA showing only a purity percentage without supporting analytical data is insufficient for research use.
Store lyophilised peptides at -20 degrees Celsius or below in sealed vials away from light. Minimise the number of times vials are opened. When reconstituting, use freshly prepared bacteriostatic water and work quickly to limit oxygen exposure. Aliquot reconstituted solutions into single-use volumes before freezing to avoid repeated freeze-thaw cycles. Source peptides from suppliers who seal vials under inert gas atmospheres.
| Term | Definition |
| HPLC | High-Performance Liquid Chromatography. The standard analytical method for measuring peptide purity by separating components in a sample based on their interaction with a stationary phase column. |
| Reversed-Phase HPLC | An HPLC method using a non-polar C18 stationary phase to separate peptides by hydrophobicity. The standard approach for peptide purity analysis in research settings. |
| Purity (%) | The percentage of the total sample that is the target peptide, as measured by peak area in HPLC analysis. Does not reflect absolute quantity or structural integrity. |
| Mass Spectrometry (MS) | An analytical technique that measures the mass-to-charge ratio of molecules. Used to confirm peptide identity, detect degradation fragments, and identify oxidation by molecular weight shifts. |
| Oxidation | A chemical modification caused by reaction with oxygen or reactive oxygen species. In peptides, oxidation of methionine, cysteine, or tryptophan residues alters molecular structure and reduces bioactivity. |
| Methionine sulfoxide | The oxidised form of the amino acid methionine. Produced when methionine reacts with oxygen, adding 16 daltons to the residue mass and reducing receptor binding affinity. |
| Degradation | The breakdown of the peptide chain into smaller fragments through hydrolysis, aggregation, racemisation, or enzymatic cleavage. Reduces potency and research reliability. |
| Hydrolysis | The chemical breakdown of a peptide bond by water. Accelerated by heat, extreme pH, and moisture contamination. A primary mechanism of peptide degradation during storage. |
| Lyophilisation | Freeze-drying. A preservation method that removes moisture from a peptide sample under vacuum, producing a stable dry powder. Lyophilised peptides are more resistant to degradation than solutions. |
| CoA | Certificate of Analysis. A supplier document confirming the identity, purity, quantity, and quality of a specific peptide batch. A complete CoA includes HPLC chromatogram, MS data, and batch-specific test results. |
| Quantitative HPLC | An HPLC method using a certified reference standard to calculate the absolute mass of a target compound in a sample, rather than just its relative percentage. |
| Inert gas sealing | The practice of sealing peptide vials under nitrogen or argon gas to displace oxygen and prevent oxidative degradation during storage and transit. |
| Karl Fischer titration | An analytical method used to measure the water content of a lyophilised sample. Residual moisture above acceptable levels accelerates peptide degradation. |
| Related Entity Pages-> Peptides — The Master Reference Guide hplcpeptides.com/wiki/peptides-> Peptide Purity and Certificate of Analysis (CoA) hplcpeptides.com/wiki/peptide-purity-coa-> BPC-157 — Tissue Repair and Gut Health Research hplcpeptides.com/wiki/bpc-157-> Epithalon — Anti-Ageing and Telomere Research hplcpeptides.com/wiki/epithalon-> Dr William Seeds — Peptide Therapy Protocols hplcpeptides.com/wiki/dr-william-seeds
-> Peptide Bioavailability and Delivery Methods hplcpeptides.com/wiki/peptide-bioavailability -> TB-500 (Thymosin Beta-4) — Recovery and Regeneration hplcpeptides.com/wiki/tb-500 |
| About This PageThis entity page was created and is maintained by the HPLC Peptides editorial team in collaboration with research advisors specialising in analytical chemistry and peptide science. Content is reviewed against current peer-reviewed literature and updated periodically. This page is intended for informational and research reference purposes only and does not constitute medical or therapeutic advice.Associated authority: Dr William Seeds — see hplcpeptides.com/wiki/dr-william-seeds for full credentials and protocol references. |
hplcpeptides.com/wiki/peptide-testing | Entity Page v1.0 | April 2026
